Safety and Pharmacodynamics Study of AGN-207281 Ophthalmic Solutions Compared With Timolol Ophthalmic Solution or Placebo in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma

Clinical trial NCT01215786 · COMPLETED

Trial details

NCT number: NCT01215786
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Glaucoma, Open-Angle Ocular Hypertension

Start date: 2010-10-01
Primary completion: 2010-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.